RxSight Inc.

RXST | NASDAQ

Price Alert Chart Builder DCF Calculator

$5.14

-$0.06 (-1.15%)

At close: Sep 21, 2026, 4:00 PM ET

$5.06

-$0.08 (-1.56%)

Pre-market: Sep 22, 2026, 7:35 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.15%

(1D)

Rating

Updated: Aug 14, 2026

45.5

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $212.78M

1D Range

5.08 5.22

52W Range

4.48 13.22

Valuation (TTM)

PE -4.55

PB 0.81

EV/EBITDA -0.34

Valuation (NTM)

Forward PE N/A

Forward PEG -0.19

Price Target $7.50

Cash Flow

FCF Yield -18.2%

SBC Adj. FCF Yield -36.7%

SBC Impact -101.2%

Margins

Gross Margin 77.5%

Operating Margin -43.2%

FCF Margin -30.4%

Growth (CAGR)

Revenue 3Y | 5Y 23.9% | 48.8%

Dil EPS 3Y | 5Y -5.6% | 26.7%

FCF 3Y | 5Y -2.8% | 16.4%

Returns

ROA -13.3%

ROE -17.4%

ROIC -20.1%

Financial Health

Net Cash

$208.8M

Current Ratio 4.07

Interest Coverage -3,674.20

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light...

Sector Healthcare

Industry Medical - Devices

Employees 461

IPO Date Jul 29, 2021

Website www.rxsight.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 4, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$6.75

Upside

+31.32%

Buy (1)

Hold (3)

Sell (2)

Analyst Details ➞